Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Teva Branded Pharmaceutical Products R&D LLC

Clinicaltrial registered3 Nov 2026

Teva Branded Pharmaceutical Products R&D LLC

3 Nov 2026: Trial registered · Real-World Impact of TV-44749 in Adults With Schizophrenia. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
3 Nov 2026
Title
Real-World Impact of TV-44749 in Adults With Schizophrenia
Conditions
Schizophrenia
Study Type
Observational
Status
Not Yet Recruiting
Reference
NCT07913100
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Teva Branded Pharmaceutical Products R&D LLC

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Teva Branded Pharmaceutical Products R&D LLC in our registers.

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.